ArticleFrontiers in oncology2022

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.

H S Gabryś et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.